References
Alzahouri, K., C. Lejeune, et al. (2005). "Cost-effectiveness analysis of strategies
introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the
French healthcare system perspective." Clin Radiol 60(4): 479-92.
Bedford, M. and M. N. Maisey (2004). "Requirements for clinical PET: comparisons
within Europe.[see comment]." European Journal of Nuclear Medicine & Molecular
Imaging 31(2): 208-21.
Bradbury et al. Health Technology Board Scotland, “Positron emission tomography
(PET) imaging in cancer management” October 2002.
Briggs A., Claxton K. and Sculpher MJ. Decision analytic modelling for the evaluation of
health technologies. O.U.P., Oxford, 2006.
Buscombe, J. and E. O'Rourke (2007). "Is 18F FDG PET-CT cost effective in lung
cancer?" Expert Rev Anticancer Ther 7(4): 471-6.
Chiti, A., F. A. Schreiner, et al. (1999). "Nuclear medicine procedures in lung cancer."
Eur J Nucl Med 26(5): 533-55.
Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung
Cancer. Australian Government; National Health and Research Council. 2004.
Devaraj, A., G. J. Cook, et al. (2007). "PET/CT in non-small cell lung cancer staging-
promises and problems." Clinical Radiology 62(2): 97-108.
Dietlein, M., K. Weber, et al. (2000). "Cost-effectiveness of FDG-PET for the
management of potentially operable non-small cell lung cancer: priority for a PET-based
strategy after nodal-negative CT results." Eur J Nucl Med 27(11): 1598-609.
Drummond et al, Methods for the Economic Evaluation of Health Care Programmes;
Third edition. (Oxford, O.U.P, 2005)
Drummond et al Economic evaluation in Health care: Merging theory and practice.
(Oxford, O.U.P, 2001)
Gambhir, S. S., C. K. Hoh, et al. (1996). "Decision tree sensitivity analysis for cost-
effectiveness of FDG-PET in the staging and management of non-small-cell lung
carcinoma." J Nucl Med 37(9): 1428-36.
Hayashi, K., K. Abe, et al. (2005). "Should mediastinoscopy actually be incorporated into
the FDG PET strategy for patients with non-small cell lung carcinoma?" Annals of
Nuclear Medicine 19(5): 393-8.
More intriguing information
1. A model-free approach to delta hedging2. AN ANALYTICAL METHOD TO CALCULATE THE ERGODIC AND DIFFERENCE MATRICES OF THE DISCOUNTED MARKOV DECISION PROCESSES
3. The name is absent
4. Top-Down Mass Analysis of Protein Tyrosine Nitration: Comparison of Electron Capture Dissociation with “Slow-Heating” Tandem Mass Spectrometry Methods
5. The name is absent
6. Are combination forecasts of S&P 500 volatility statistically superior?
7. Industrial Employment Growth in Spanish Regions - the Role Played by Size, Innovation, and Spatial Aspects
8. The name is absent
9. Nonlinear Production, Abatement, Pollution and Materials Balance Reconsidered
10. The name is absent